Daniel S. Fierer

4.3k total citations
36 papers, 1.0k citations indexed

About

Daniel S. Fierer is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Daniel S. Fierer has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 21 papers in Epidemiology and 15 papers in Infectious Diseases. Recurrent topics in Daniel S. Fierer's work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Daniel S. Fierer is often cited by papers focused on Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Daniel S. Fierer collaborates with scholars based in United States, Australia and Austria. Daniel S. Fierer's co-authors include M D Challberg, SP Bajaj, SI Rapaport, Douglas T. Dieterich, Andrea D. Branch, Raymond T. Chung, Emma Kaplan‐Lewis, Viviana Simon, Raymond Alvarez and Benjamin K. Chen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Daniel S. Fierer

34 papers receiving 992 citations

Peers

Countries citing papers authored by Daniel S. Fierer

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Fierer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Fierer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Fierer more than expected).

Fields of papers citing papers by Daniel S. Fierer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Fierer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Fierer. The network helps show where Daniel S. Fierer may publish in the future.

Co-authorship network of co-authors of Daniel S. Fierer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Fierer. A scholar is included among the top collaborators of Daniel S. Fierer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Fierer. Daniel S. Fierer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neurocognitive trajectories in long COVID: Evidence from longitudinal analyses 2025 ·Brain Behavior & Immunity - Health ·Jacqueline Becker, Jia Li, Jenny J. Lin, Alex D. Federman, Emilia Bagiella, Minal Kale, Daniel S. Fierer, Logan Bartram, Juan P. Wisnivesky	0
2	Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression 2022 ·The Lancet HIV ·(unknown), Behzad Hajarizadeh, Sahar Bajis, Matthew Law, Naveed Z. Janjua, Daniel S. Fierer, David Chromy, Jürgen K. Rockstroh, Thomas Martin, Patrick Ingiliz, Chien‐Ching Hung, Gregory J. Dore, Marianne Martinello, Gail Matthews	28
3	Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing 2020 ·PLoS ONE ·Hui Li, Kristen Marks, Andrew H. Talal, (unknown), Bisher Akil, Asa Radix, Shirish Huprikar, Andrea D. Branch, Shuyi Wang, George M. Shaw, Daniel S. Fierer	5
4	Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate 2018 ·Journal of Antimicrobial Chemotherapy ·Christine E. MacBrayne, Kristen Marks, Daniel S. Fierer, Susanna Naggie, Raymond T. Chung, Michael D. Hughes, Arthur Y. Kim, Marion G. Peters, Diana M. Brainard, Sharon M. Seifert, José Castillo‐Mancilla, Lane R. Bushman, Peter L. Anderson, Jennifer J. Kiser	17
5	Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG 2017 ·JCI Insight ·Raymond Alvarez, Ana M. Maestre, Kenneth Law, Natasha D. Durham, María Inés Barría, Akiko Ishii‐Watabe, Minoru Tada, Manav Kapoor, (unknown), (unknown), Daniel S. Fierer, Ana Fernández-Sesma, Viviana Simon, Benjamin K. Chen	10
6	Treatment of “acute” hepatitis C virus in human immunodeficiency virus-infected men with short-course sofosbuvir/ledipasvir 2017 ·Journal of Hepatology ·Daniel S. Fierer, (unknown), (unknown)	2
7	Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection 2017 ·Addictive Disorders & Their Treatment ·Stevan A. Gonzalez, Daniel S. Fierer, Andrew H. Talal	27
8	Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C 2017 ·Clinical Infectious Diseases ·Susanna Naggie, Kristen Marks, Michael D. Hughes, Daniel S. Fierer, Christine E. MacBrayne, Arthur Kim, Kimberly Hollabaugh, Jhoanna Roa, (unknown), Diana M. Brainard, John G. McHutchison, Marion G. Peters, Jennifer J. Kiser, Raymond T. Chung	28
9	Increased Mitochondrial Genetic Diversity in Persons Infected With Hepatitis C Virus 2016 ·Cellular and Molecular Gastroenterology and Hepatology ·David S. Campo, (unknown), Brian L. Pearlman, Daniel S. Fierer, Sumathi Ramachandran, Gilberto Vaughan, (unknown), Zoya Dimitrova, Pavel Skums, Yury Khudyakov	6
10	Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV 2016 ·Clinical Infectious Diseases ·(unknown), (unknown), (unknown), Kian Bichoupan, (unknown), Erin Doyle, (unknown), Neal M. Patel, (unknown), Donald Gardenier, Joseph A. Odin, Thomas D. Schiano, Daniel S. Fierer, Leonard Berkowitz, Ponni Perumalswami, Douglas T. Dieterich, Andrea D. Branch	20
11	Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease 2016 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jeffrey J. Weiss, Ioannis Konstantinidis, (unknown), Daniel S. Fierer, Donald Gardenier, (unknown), Tony Kang, (unknown), (unknown), Marlene C. Lira, (unknown), Hillary R. Bogner, Juan P. Wisnivesky, Christina Wyatt	14
12	Treatment of Early Hepatitis C Infection in HIV-Infected Men—When to Treat, Whom, and with What? 2016 ·Current treatment options in infectious diseases ·Lynn E. Taylor, Daniel S. Fierer	2
13	Acute HCV in HIV-Infected MSM: Modes of Acquisition, Liver Fibrosis, and Treatment 2015 ·Current HIV/AIDS Reports ·Emma Kaplan‐Lewis, Daniel S. Fierer	28
14	Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-Infected Men After Primary Hepatitis C Virus Infection 2012 ·Clinical Infectious Diseases ·Daniel S. Fierer, Douglas T. Dieterich, M. Isabel Fiel, Andrea D. Branch, Kristen Marks, Dahlene N. Fusco, Ricky Hsu, Davey M. Smith, Joshua Fierer	46
15	Epidemic of Sexually Transmitted Hepatitis C Virus Infection Among HIV-Infected Men 2010 ·Current Infectious Disease Reports ·Daniel S. Fierer	10
16	Liver Fibrosis during an Outbreak of Acute Hepatitis C Virus Infection in HIV‐Infected Men: A Prospective Cohort Study 2008 ·The Journal of Infectious Diseases ·Daniel S. Fierer, Alison Uriel, Damaris Carriero, Arielle Klepper, Douglas T. Dieterich, Michael P. Mullen, Swan N. Thung, Maria Isabel Fiel, Andrea D. Branch	79
17	Absence of Erythrocyte‐Associated HIV‐1 In Vivo 2007 ·The Journal of Infectious Diseases ·Daniel S. Fierer, Jesus Vargas, Niraj Patel, (unknown)	5
18	Thalidomide for the Treatment of AIDS-Associated Wasting 2000 ·AIDS Research and Human Retroviruses ·Gilla Kaplan, Steve D. Thomas, Daniel S. Fierer, Kathleen Mulligan, Patrick Haslett, W. Jeffrey Fessel, Leon G. Smith, Karin A. Kook, David Stirling, Morris Schambelan	67
19	The Stoichiometry of Binding of the Herpes Simplex Virus Type 1 Origin Binding Protein, UL9, to OriS 1995 ·Journal of Biological Chemistry ·Daniel S. Fierer, M D Challberg	19
20	A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome 1983 ·Blood ·SP Bajaj, SI Rapaport, Daniel S. Fierer, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact